Pamela Conley is the founder of Nuvig Therapeutics. Nuvig Therapeutics has raised $208M in total funding. Latest round: Series B.
Pamela Conley is the Co-founder and Chief Scientific Officer of Nuvig Therapeutics, a biotechnology company developing novel immunomodulatory therapeutics for chronic inflammatory and autoimmune diseases. She licensed and expanded technology from Jeffrey Ravetch’s lab at The Rockefeller University while at Portola, distilling IVIG's active anti-inflammatory components into engineered Fc fragments to create Nuvig's BESTech™ platform. She also serves as a Director at Cellphire, Inc. since 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library